Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction--a double-blind, placebo-controlled, cross-over, multiple n = 1 study.
Bottom Line: Three discontinued, two due to study length, and one on prucalopride due to unrelated malnutrition and bronchopneumonia.Four patients (three visceral myopathy and one visceral neuropathy) completed the study; prucalopride significantly improved pain in three of four patients, nausea in two, vomiting in one, bloating in four and analgesic intake.Prucalopride relieves symptoms in selected patients with chronic pseudo-obstruction.
Affiliation: University College, London, UK.Show MeSH
Related in: MedlinePlus
Mentions: Figure 1 and Table 3 show the distribution of the proportion of days with and without symptoms (pain, vomiting, nausea and bloating) for each of the four patients who completed the study, during placebo- and prucalopride- treatment days. One subject (3006) reported very few days with the presence of symptoms during both placebo and prucalopride treatment, hence there was little room for improvement. All the other subjects showed an improvement in at least one of the symptoms with active treatment.